Skip to main content
Watch Insiders
Market intelligence
SCTXSector not reported

Scribe Therapeutics, Inc. insider activity

In the last 90 days, 12 corporate insiders purchased $183,779,300 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$183,779,300
Corporate buyers
12
Latest transaction
Jul 28, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Jul 28, 2026Avoro Capital Advisors LlcCorporate insiderOpen Market Purchase2,391,238$15.16$36,259,777
Jul 28, 2026Behzad AghazadehCorporate insiderOpen Market Purchase2,391,238$15.16$36,259,777
Jul 28, 2026Avoro Ventures LlcCorporate insiderOpen Market Purchase2,391,238$15.16$36,259,777
🔒 Unlock Real-Time Alerts and 2 More High-Conviction Rows — Subscribe to Watch Insiders Premium